My husband is 10 years older than I am, in his mid-fifties and I have to tell you, this is exactly why I bought stock in this company. If this drug reduces the sexual side effects from what he is currently taking, like it or not, he's getting an injection. Just thought you'd like a female point of view too.
Way too high for this stock. If the drug in PIII had a bigger market potential then yes, then it would be like Dendreon. No such luck here. I like Versant's target of 6.50 if we get positive PIII and a couple other good PR's about the rest of the pipeline.
Take some off the table and buy back in closer to $2...someone will take this thing down at the close
'Any ideas what's happening? Can not be moving up like that with no news...'
Sure it can. It's called anticipation. This is a thinly traded stock which makes it very volatile. Positive Cetrorelix results and it continues up, negative results and it will plummet.